SMAD4 and polycystic ovary syndrome: Moreover, the Smad4 levels were considerably lower in the SA‐treated and Met‐treated rats than in the PCOS rats (p < .01), with a more pronounced decrease in the SA‐treated PCOS rats than in the Met‐treated PCOS rats (p < .05).